Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, TR-06330 Ankara, Turkey.
Mar Drugs. 2010 Jan 15;8(1):47-58. doi: 10.3390/md8010047.
In this study, thirteen sponge-derived terpenoids, including five linear furanoterpenes: furospinulosin-1 (1), furospinulosin-2 (2), furospongin-1 (3), furospongin-4 (4), and demethylfurospongin-4 (5); four linear meroterpenes: 2-(hexaprenylmethyl)-2-methylchromenol (6), 4-hydroxy-3-octaprenylbenzoic acid (7), 4-hydroxy-3-tetraprenyl-phenylacetic acid (8), and heptaprenyl-p-quinol (9); a linear triterpene, squalene (10); two spongian-type diterpenes dorisenone D (11) and 11 beta-acetoxyspongi-12-en-16-one (12); a scalarane-type sesterterpene; 12-epi-deoxoscalarin (13), as well as an indole alkaloid, tryptophol (14) were screened for their in vitro activity against four parasitic protozoa; Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum. Cytotoxic potential of the compounds on mammalian cells was also assessed. All compounds were active against T. brucei rhodesiense, with compound 8 being the most potent (IC(50) 0.60 microg/mL), whereas 9 and 12 were the most active compounds against T. cruzi, with IC(50) values around 4 microg/mL. Compound 12 showed the strongest leishmanicidal activity (IC(50) 0.75 microg/mL), which was comparable to that of miltefosine (IC(50) 0.20 microg/mL). The best antiplasmodial effect was exerted by compound 11 (IC(50) 0.43 microg/mL), followed by compounds 7, 10, and 12 with IC(50) values around 1 microg/mL. Compounds 9, 11 and 12 exhibited, besides their antiprotozoal activity, also some cytotoxicity, whereas all other compounds had low or no cytotoxicity towards the mammalian cell line. This is the first report of antiprotozoal activity of marine metabolites 1-14, and points out the potential of marine sponges in discovery of new antiprotozoal lead compounds.
在这项研究中,从海绵中分离得到了 13 种萜类化合物,包括 5 种线性呋喃萜类化合物:呋喃旋磷素-1(1)、呋喃旋磷素-2(2)、呋喃海绵素-1(3)、呋喃海绵素-4(4)和去甲呋喃海绵素-4(5);4 种线性单萜类化合物:2-(十六烷甲基)-2-甲基色醇(6)、4-羟基-3-辛烷基苯甲酸(7)、4-羟基-3-四烯基苯乙酸(8)和庚烷基-p-喹啉(9);一种线性三萜类化合物鲨烯(10);2 种海绵二萜类化合物dorisenone D(11)和 11β-乙酰氧基海绵-12-烯-16-酮(12);一种海鞘烷型倍半萜类化合物 12-表去氧沙卡林(13),以及一种吲哚生物碱色醇(14)。对它们的体外抗四种寄生原生动物的活性进行了筛选;布氏锥虫罗得西亚种、克氏锥虫、杜氏利什曼原虫和恶性疟原虫。还评估了化合物对哺乳动物细胞的细胞毒性潜力。所有化合物对布氏锥虫罗得西亚种均有活性,化合物 8 的活性最强(IC50 0.60 μg/mL),而化合物 9 和 12 对克氏锥虫的活性最强,IC50 值约为 4 μg/mL。化合物 12 对利什曼原虫的活性最强(IC50 0.75 μg/mL),与米替福新(IC50 0.20 μg/mL)相当。化合物 11(IC50 0.43 μg/mL)对恶性疟原虫的抑制作用最强,其次是化合物 7、10 和 12,IC50 值约为 1 μg/mL。化合物 9、11 和 12 除了具有抗原生动物活性外,还具有一定的细胞毒性,而其他所有化合物对哺乳动物细胞系的细胞毒性均较低或无。这是海洋代谢物 1-14 具有抗原生动物活性的首次报道,指出了海洋海绵在发现新的抗原生动物先导化合物方面的潜力。